Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.8678
+0.0466 (5.67%)
Jul 27, 2026, 9:40 AM EDT - Market open
Onconetix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.72 | 5.22 | 0.65 | 4.55 | 25.75 | 1.93 |
Cash & Short-Term Investments | 3.72 | 5.22 | 0.65 | 4.55 | 25.75 | 1.93 |
Cash Growth | 135.61% | 707.53% | -85.80% | -82.31% | 1235.39% | -55.24% |
Accounts Receivable | 0.04 | 0.3 | 0.03 | 0.15 | 0.04 | 0.15 |
Other Receivables | - | 0.05 | - | - | - | - |
Total Trade Receivables | 0.04 | 0.35 | 0.03 | 0.15 | 0.04 | 0.15 |
Inventory | 0.14 | 0.15 | 0.06 | 0.36 | - | - |
Other Current Assets | 0.43 | 0.35 | 0.21 | 0.77 | 0.47 | 0.23 |
Total Current Assets | 4.33 | 6.07 | 0.95 | 5.84 | 26.26 | 3.07 |
Net Property, Plant & Equipment | 0.07 | 0.09 | 0.18 | 0.21 | 0.01 | 0.01 |
Other Intangible Assets | - | - | - | 25.41 | - | - |
Goodwill | 10.2 | 18.55 | 27.05 | 55.68 | - | - |
Other Long-Term Assets | 0.23 | 0.23 | - | 0.38 | 0.04 | 0.76 |
Total Assets | 14.83 | 24.93 | 28.18 | 87.52 | 26.31 | 3.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.53 | 1.76 | 3.79 | 5.3 | 1.5 | 0.58 |
Accrued Expenses | 0.28 | 0.34 | 0.89 | 2.2 | 2.41 | 1.06 |
Short-Term Debt | 0.25 | - | 9.33 | 9.62 | - | - |
Current Portion of Leases | 0.02 | 0.02 | 0.12 | 0.07 | - | - |
Other Current Liabilities | 0.98 | 7.01 | 4.17 | 0 | 0.01 | - |
Total Current Liabilities | 3.07 | 9.14 | 18.29 | 17.19 | 3.92 | 1.64 |
Long-Term Debt | - | - | - | 0.12 | - | - |
Long-Term Leases | 0.02 | 0.02 | - | 0.07 | - | - |
Other Long-Term Liabilities | - | - | 0.28 | 4.49 | - | - |
Total Long-Term Liabilities | 0.02 | 0.02 | 0.28 | 4.69 | - | - |
Total Liabilities | 3.08 | 9.16 | 18.57 | 21.88 | 3.92 | 1.64 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Preferred Stock | - | - | - | - | - | 0 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | -0.63 | -0.63 | -0.63 | -0.63 | -0.57 | - |
Additional Paid-in Capital | 148.24 | 147.84 | 127.58 | 49.43 | 42.33 | 7.4 |
Accumulated Other Comprehensive Income | -0.44 | -0.23 | -2.72 | 2.38 | - | - |
Retained Earnings | -135.43 | -131.21 | -115.68 | -56.79 | -19.38 | -5.96 |
Total Common Shareholders' Equity | 11.75 | 15.76 | 8.54 | -5.6 | 22.39 | 1.45 |
Minority Interest | 0 | 0 | 1.07 | 71.24 | - | - |
Shareholders' Equity | 11.75 | 15.76 | 8.54 | 1.4 | 22.39 | 1.45 |
Total Liabilities & Equity | 14.83 | 24.93 | 28.18 | 87.52 | 26.31 | 3.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.29 | 0.05 | 9.45 | 9.89 | 0 | 0 |
Net Cash (Debt) | 3.43 | 5.17 | -8.8 | -5.33 | 25.75 | 1.93 |
Net Cash Growth | - | - | - | - | 1235.39% | -55.24% |
Net Cash Per Share | 102.52 | 275.78 | - | - | - | - |
Book Value | 11.75 | 15.76 | 8.54 | -5.6 | 22.39 | 1.45 |
Book Value Per Share | 351.47 | 840.61 | - | - | - | - |
Tangible Book Value | 1.54 | -2.78 | -18.51 | -86.69 | 22.39 | 1.45 |
Tangible Book Value Per Share | 46.17 | -148.47 | - | - | - | - |